SS
CNMD icon

SBI Securities’s CONMED CNMD Stock Holding History

SBI Securities’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$47 – 4069
2025
Q3 		$47 Buy
+1
New +$52 ﹤0.01% 3736

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

SBI Securities's CNMD Position: Q4 2025 in Review

SBI Securities sold out of CONMED (CNMD) in Q4 2025, closing a stake of 1 share — an estimated $47 sold.

SBI Securities first reported a position in CNMD in Q3 2025 and held it in 1 quarter. The position peaked at $47 in Q3 2025. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • SBI Securities reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 1 CONMED share in Q4 2025, an estimated $47.
  • SBI Securities first reported a position in CONMED in Q3 2025 and held it in 1 quarter.
  • SBI Securities's CONMED position peaked at $47 in Q3 2025.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.